McKinley Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

McKinley Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,300	Closed	-$81K	–	307
2019 Q1	$81K	Hold	1,300	–	–	0.01%	203
2018 Q4	$78K	Sell	1,300 -2,445	-65%	-$147K	0.01%	205
2018 Q3	$242K	Sell	3,745 -311	-8%	-$17.4K	0.02%	193
2018 Q2	$182K	Sell	4,056 -1,460	-26%	-$58.2K	0.01%	228
2018 Q1	$171K	Sell	5,516 -152,347	-97%	-$5.01M	0.01%	223
2017 Q4	$4.72M	Buy	157,863 +68	+0%	+$1.97K	0.24%	79
2017 Q3	$5.21M	Buy	157,795 +2,407	+2%	+$83.4K	0.21%	82
2017 Q2	$5.2M	Sell	155,388 -23,120	-13%	-$690K	0.19%	82
2017 Q1	$5.17M	Sell	178,508 -38,496	-18%	-$954K	0.19%	82
2016 Q4	$4.85M	Sell	217,004 -173,769	-44%	-$3.4M	0.19%	101
2016 Q3	$7.26M	Sell	390,773 -77,689	-17%	-$1.47M	0.26%	102
2016 Q2	$7.64M	Buy	+468,462	New	+$6.89M	0.37%	85

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

McKinley Capital Management's BEAT Position: Q2 2019 in Review

McKinley Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 1,300 shares — an estimated $81K sold.

McKinley Capital Management first reported a position in BEAT in Q2 2016 and held it in 12 quarters. The position peaked at $7.64M in Q2 2016. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

McKinley Capital Management reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
McKinley Capital Management sold 1,300 BioTelemetry, Inc. shares in Q2 2019, an estimated $81K.
McKinley Capital Management first reported a position in BioTelemetry, Inc. in Q2 2016 and held it in 12 quarters.
McKinley Capital Management's BioTelemetry, Inc. position peaked at $7.64M in Q2 2016.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on McKinley Capital Management's 13F filing for Q2 2019, filed 7 Aug 2019.